![]() ![]() ![]() ![]() Various Chinese government agencies, including the State Council, the National Health Commission, the Ministry of Science and Technology and Foreign Ministry, did not respond to NPR's requests for comment. ![]() Many of the details were not made public, however, and he did not respond when NPR emailed him for clarification. The government banned He from doing anything related to assisted human reproductive technology, and imposed limits on his work relating to human genes. He's conviction also came with conditions on future work. The scientist's move back into the lab comes at a time of lingering questions about his past work - and is raising new concerns among experts about his motivations and those of the Chinese government, which jailed him and tightened regulations on gene editing in the wake of his experiment on embryos. "They want me to develop therapy for them," he tells NPR in an interview. The patients, and their families, had heard about He from his baby project, he says. "There over 2,000 DMD patients, they are writing to me, text me, make phone call to me," he says.ĭMD, or Duchenne muscular dystrophy, is a genetic disease that causes muscles to waste away. He was swiftly detained and a Chinese court later sentenced him to three years in prison for "illegal medical practices."Ībout a year ago he got out, and says he took up golf. There were accusations that the biophysicist had grossly violated medical ethics some critics compared him to Dr. The news sent shockwaves around the world. He Jiankui announced nearly five years ago that he had created the first gene-edited babies, twin girls named Lulu and Nana. "Automation in healthcare isn't about closing the gap between need and lack of clinicians - it's about equipping our clinicians with tools they need to be able to continue to provide high-quality care more efficiently.BEIJING - In a mostly empty coworking office on the outskirts of China's capital, a scientist whose name is etched in history is trying to stage a comeback. "There has never been a time in healthcare when it has been more important for us to embrace automation," said Matt Warrens, managing director of UnityPoint Health Ventures, in a news release. Carta Healthcare said it plans to use the investment to scale its operations and develop more products for health systems. It secured the first $20 million in November with participation from Somerville, Mass.-based Mass General Brigham and the University of Colorado Healthcare Innovation Fund, which includes Aurora-based UCHealth and Children's Hospital Colorado. The company, which collects, analyzes and gleans insights from clinical data, closed the round June 8. Houston-based Memorial Hermann Health System and West Des Moines, Iowa-based UnityPoint Health invested in a $25 million series B funding round for data analytics company Carta Healthcare. Past Issues - Becker's Clinical Leadership & Infection Control.Current Issue - Becker's Clinical Leadership & Infection Control.Becker's Cardiology + Heart Surgery Podcast.Becker's Ambulatory Surgery Centers Podcast.Becker’s Digital Health + Health IT Podcast.Digital Innovation + Patient Experience and Marketing Virtual Event.Conference Reviewers: Request for More Information.The Future of Dentistry Roundtable October.29th Annual Meeting - The Business & Operations of ASCs.8th Annual Health IT + Digital Health + RCM Conference.20th Annual Spine, Orthopedic & Pain Management-Driven ASC Conference.Clinical Leadership & Infection Control. ![]()
0 Comments
Leave a Reply. |